Susquehanna Portfolio Strategies, LLC Crispr Therapeutics Ag Transaction History
Susquehanna Portfolio Strategies, LLC
- $4.58 Trillion
- Q2 2025
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 31,015 shares of CRSP stock, worth $1.69 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
31,015
Previous 19,050
62.81%
Holding current value
$1.69 Million
Previous $648 Million
132.71%
% of portfolio
0.03%
Previous 0.28%
Shares
5 transactions
Others Institutions Holding CRSP
# of Institutions
539Shares Held
68.5MCall Options Held
3.6MPut Options Held
2.21M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$556 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$305 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$201 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$179 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$155 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.26B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....